NSRX: CEO Buys 6,550 Shares
Nasus Pharma CEO Dan Benjamin Teleman buys 6,550 shares at $3.1
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Nasus Pharma CEO Dan Benjamin Teleman buys 6,550 shares at $3.1
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.